The findings hint at why the ABYSS trial failed to show it was safe to stop beta-blockers after an MI in stable patients.

With updated Phase I/Ib data in hand, Arcus will launch a Phase III trial as it aims to compete with Merck, whose drug ...

A new three-drug combination could help women with a common form of aggressive breast cancer live longer, research suggests.

The lead author said the study also showed the inavolisib-based therapy "more than doubled the time before their cancer progressed or worsened".

The main finding of the observational study, published in the journal Neurology, suggests that alpha-blocker drugs used to treat urinary symptoms caused by an enlarged prostate gland may reduce ...

In a nutshell One injection of zilebesiran every six months could replace daily blood pressure pills for some patients Blood ...

A Hudson man was arrested May 30 after state police found large quantities of illegal drugs during a traffic stop on the ...

There’s a condition called diverticulosis that affects the gut. In this condition, small pouch-like bumps form in the lining ...

Inversago is working on peripherally acting CB1 receptor blocker therapies, with the receptor thought to play a role in appetite, and Embark is focused on a potential drug to boost calorie ...